疫苗前沿 | 3-17岁人群接种两剂克尔来福疫苗是安全的，且能够诱导较强的抗体反应

NOTES TO EDITORS

This study was funded by the National Key Research and Development Program and the Beijing Science and Technology Program. It was conducted by researchers from Hebei Provincial Center for Disease Control and 

Prevention, Sinovac Biotech Ltd, National Institutes for Food and Drug Control, Zanhuang County Center for Disease Control and Prevention, Beijing Key Tech Statistics Technology Co., Ltd., and Sinovac Life Sciences Co, Ltd, China. 

[1] https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30987-7/fulltext; https://www.thelancet.com/article/S1473-3099(20)30843-4/fulltext

[2] Quote direct from author and cannot be found in the text of the Article.